Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by Cairn Investment Group Inc.

Cairn Investment Group Inc. boosted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 8.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 31,029 shares of the pharmacy operator’s stock after acquiring an additional 2,450 shares during the period. Cairn Investment Group Inc.’s holdings in Walgreens Boots Alliance were worth $1,159,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Sage Private Wealth Group LLC purchased a new position in shares of Walgreens Boots Alliance in the 3rd quarter valued at about $25,000. EverSource Wealth Advisors LLC lifted its stake in Walgreens Boots Alliance by 289.4% during the third quarter. EverSource Wealth Advisors LLC now owns 915 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 680 shares during the last quarter. Bank of New Hampshire boosted its holdings in Walgreens Boots Alliance by 56.4% in the third quarter. Bank of New Hampshire now owns 960 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 346 shares in the last quarter. Blume Capital Management Inc. increased its stake in Walgreens Boots Alliance by 35.7% in the third quarter. Blume Capital Management Inc. now owns 950 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 250 shares during the last quarter. Finally, Ten Capital Wealth Advisors LLC raised its holdings in Walgreens Boots Alliance by 431.1% during the third quarter. Ten Capital Wealth Advisors LLC now owns 1,179 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 957 shares in the last quarter. Institutional investors and hedge funds own 56.71% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on WBA shares. Credit Suisse Group lowered their target price on shares of Walgreens Boots Alliance from $42.00 to $41.00 and set a “neutral” rating for the company in a report on Friday, January 6th. Loop Capital began coverage on Walgreens Boots Alliance in a report on Wednesday, February 22nd. They set a “buy” rating and a $45.00 price objective on the stock. JPMorgan Chase & Co. reduced their target price on Walgreens Boots Alliance from $42.00 to $40.00 and set a “neutral” rating for the company in a report on Friday, January 6th. Cowen raised Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and upped their target price for the company from $43.00 to $54.00 in a research report on Tuesday, November 22nd. Finally, Cowen raised Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $43.00 to $54.00 in a research report on Tuesday, November 22nd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $43.43.

Walgreens Boots Alliance Stock Down 1.5 %

Shares of Walgreens Boots Alliance stock opened at $32.91 on Friday. The company has a market cap of $28.38 billion, a P/E ratio of -9.57, a PEG ratio of 1.48 and a beta of 0.72. The firm has a fifty day moving average of $35.86 and a two-hundred day moving average of $36.46. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.36 and a current ratio of 0.70. Walgreens Boots Alliance, Inc. has a one year low of $30.39 and a one year high of $48.62.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last announced its quarterly earnings data on Thursday, January 5th. The pharmacy operator reported $1.16 EPS for the quarter, beating analysts’ consensus estimates of $1.15 by $0.01. Walgreens Boots Alliance had a negative net margin of 2.24% and a positive return on equity of 13.57%. The firm had revenue of $33.38 billion during the quarter, compared to the consensus estimate of $33.04 billion. During the same quarter last year, the firm earned $1.68 earnings per share. The firm’s revenue was down 1.5% compared to the same quarter last year. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 4.5 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 10th. Investors of record on Thursday, February 16th were paid a $0.48 dividend. The ex-dividend date was Wednesday, February 15th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 5.83%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -55.81%.

About Walgreens Boots Alliance

(Get Rating)

Walgreens Boots Alliance, Inc engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment.

Featured Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.